These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16677948)

  • 1. A cluster-based quantitative procedure in an fMRI study of Parkinson's disease.
    Macrì MA; Garreffa G; Giove F; Moraschi M; Giulietti G; Modugno N; Colonnese C; Maraviglia B
    Magn Reson Imaging; 2006 May; 24(4):419-24. PubMed ID: 16677948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural basis for impaired time reproduction in Parkinson's disease: an fMRI study.
    Elsinger CL; Rao SM; Zimbelman JL; Reynolds NC; Blindauer KA; Hoffmann RG
    J Int Neuropsychol Soc; 2003 Nov; 9(7):1088-98. PubMed ID: 14738289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compensatory cortical mechanisms in Parkinson's disease evidenced with fMRI during the performance of pre-learned sequential movements.
    Mallol R; Barrós-Loscertales A; López M; Belloch V; Parcet MA; Avila C
    Brain Res; 2007 May; 1147():265-71. PubMed ID: 17368575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of apomorphine on attentional processing in Parkinson's disease.
    Růzicka E; el Massioui F; Pillon B; Dubois B; Renault B; Agid Y
    Sb Lek; 1999; 100(2):85-99. PubMed ID: 11220166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.
    Palmer SJ; Eigenraam L; Hoque T; McCaig RG; Troiano A; McKeown MJ
    Neuroscience; 2009 Jan; 158(2):693-704. PubMed ID: 18722512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. fMRI study of motor cortex activity modulation in early Parkinson's disease.
    Moraschi M; Giulietti G; Giove F; Guardati M; Garreffa G; Modugno N; Colonnese C; Maraviglia B
    Magn Reson Imaging; 2010 Oct; 28(8):1152-8. PubMed ID: 20423753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological MRI mapping of age-associated changes in basal ganglia circuitry of awake rhesus monkeys.
    Zhang Z; Andersen A; Grondin R; Barber T; Avison R; Gerhardt G; Gash D
    Neuroimage; 2001 Nov; 14(5):1159-67. PubMed ID: 11697947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apomorphine: a rapid rescue agent for the management of motor fluctuations in advanced Parkinson disease.
    Kolls BJ; Stacy M
    Clin Neuropharmacol; 2006; 29(5):292-301. PubMed ID: 16960475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of functional connectivity of the motor network in the resting state in Parkinson's disease.
    Wu T; Wang L; Chen Y; Zhao C; Li K; Chan P
    Neurosci Lett; 2009 Aug; 460(1):6-10. PubMed ID: 19463891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfusion-weighted dynamic susceptibility (DSC) MRI: basal ganglia hemodynamic changes after apomorphine in Parkinson's disease.
    Brusa L; Bassi A; Pierantozzi M; Gaudiello S Frasca F; Floris R; Stanzione P
    Neurol Sci; 2002 Sep; 23 Suppl 2():S61-2. PubMed ID: 12548344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study.
    García Ruiz PJ; Sesar Ignacio A; Ares Pensado B; Castro García A; Alonso Frech F; Alvarez López M; Arbelo González J; Baiges Octavio J; Burguera Hernández JA; Calopa Garriga M; Campos Blanco D; Castaño García B; Carballo Cordero M; Chacón Peña J; Espino Ibáñez A; Gorospe Onisalde A; Giménez-Roldán S; Granés Ibáñez P; Hernández Vara J; Ibáñez Alonso R; Jiménez Jiménez FJ; Krupinski J; Kulisevsky Bojarsky J; Legarda Ramírez I; Lezcano García E; Martínez-Castrillo JC; Mateo González D; Miquel Rodríguez F; Mir P; Muñoz Fargas E; Obeso Inchausti J; Olivares Romero J; Olivé Plana J; Otermin Vallejo P; Pascual Sedano B; Pérez de Colosía Rama V; Pérez López-Fraile I; Planas Comes A; Puente Periz V; Rodríguez Oroz MC; Sevillano García D; Solís Pérez P; Suárez Muñoz J; Vaamonde Gamo J; Valero Merino C; Valldeoriola Serra F; Velázquez Pérez JM; Yáñez Baña R; Zamarbide Capdepon I
    Mov Disord; 2008 Jun; 23(8):1130-6. PubMed ID: 18442107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased cortical inhibition induced by apomorphine in patients with Parkinson's disease.
    Manfredi L; Garavaglia P; Beretta S; Pellegrini G
    Neurophysiol Clin; 1998 Feb; 28(1):31-8. PubMed ID: 9562997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal ganglia activation in Parkinson's disease.
    Holden A; Wilman A; Wieler M; Martin WR
    Parkinsonism Relat Disord; 2006 Mar; 12(2):73-7. PubMed ID: 16458037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired activity of the supplementary motor area in akinetic patients with Parkinson's disease. Improvement by the dopamine agonist apomorphine.
    Rascol OJ; Sabatini U; Chollet F; Montastruc JL; Marc-Vergnes JP; Rascol A
    Adv Neurol; 1993; 60():419-21. PubMed ID: 8420165
    [No Abstract]   [Full Text] [Related]  

  • 16. Future delivery systems for apomorphine in patients with Parkinson's disease.
    van Laar T; Van der Geest R; Danhof M
    Adv Neurol; 1999; 80():535-44. PubMed ID: 10410768
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease.
    Fera F; Nicoletti G; Cerasa A; Romeo N; Gallo O; Gioia MC; Arabia G; Pugliese P; Zappia M; Quattrone A
    Brain Res Bull; 2007 Sep; 74(1-3):75-83. PubMed ID: 17683792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compromised circadian function in Parkinson's disease: enucleation augments disease severity in the unilateral model.
    Willis GL; Kelly AM; Kennedy GA
    Behav Brain Res; 2008 Nov; 193(1):37-47. PubMed ID: 18547659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebral ERD/ERS in voluntary movement and in cognitive visuomotor task.
    Rektor I; Sochůrková D; Bocková M
    Prog Brain Res; 2006; 159():311-30. PubMed ID: 17071240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing.
    Mongeon D; Blanchet P; Messier J
    Neuroscience; 2009 Jan; 158(2):426-40. PubMed ID: 18996173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.